Loading...
OptiNose, Inc.
OPTN•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$9.60
$0.00(0.00%)
OptiNose, Inc. (OPTN) Financial Performance & Income Statement Overview
Review OptiNose, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
10.20%
↑ 10.20%
Operating Income Growth
28.26%
↑ 28.26%
Net Income Growth
39.29%
↑ 39.29%
Operating Cash Flow Growth
-118.61%
↓ 118.61%
Operating Margin
-19.34%
↓ 19.34%
Gross Margin
90.53%
↑ 90.53%
Net Profit Margin
-36.52%
↓ 36.52%
ROE
64.39%
↑ 64.39%
ROIC
26.32%
↑ 26.32%
OptiNose, Inc. (OPTN) Income Statement & Financial Overview
Review OptiNose, Inc.'s (OPTN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $22.42M | $20.44M | $20.49M | $14.88M |
| Cost of Revenue | $1.95M | $2.06M | $1.98M | $1.31M |
| Gross Profit | $20.46M | $18.37M | $18.51M | $13.57M |
| Gross Profit Ratio | $0.91 | $0.90 | $0.90 | $0.91 |
| R&D Expenses | $772000.00 | $949000.00 | $928000.00 | $1.21M |
| SG&A Expenses | $19.34M | $19.48M | $24.13M | $20.43M |
| Operating Expenses | $20.11M | $20.42M | $25.06M | $21.64M |
| Total Costs & Expenses | $22.06M | $22.49M | $27.04M | $22.95M |
| Interest Income | $733000.00 | $913000.00 | $809000.00 | $296000.00 |
| Interest Expense | $4.85M | $5.29M | $4.95M | $4.97M |
| Depreciation & Amortization | $66000.00 | $65000.00 | $70000.00 | $83000.00 |
| EBITDA | $4.55M | $5.83M | -$2.55M | -$9.01M |
| EBITDA Ratio | $0.20 | $0.29 | -$0.12 | -$0.61 |
| Operating Income | $355000.00 | -$2.05M | -$6.55M | -$8.07M |
| Operating Income Ratio | $0.02 | -$0.10 | -$0.32 | -$0.54 |
| Other Income/Expenses (Net) | -$715000.00 | $2.52M | -$1.03M | -$5.99M |
| Income Before Tax | -$360000.00 | $467000.00 | -$7.58M | -$14.07M |
| Income Before Tax Ratio | -$0.02 | $0.02 | -$0.37 | -$0.95 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $39724.00 |
| Net Income | -$360000.00 | $467000.00 | -$7.58M | -$14.07M |
| Net Income Ratio | -$0.02 | $0.02 | -$0.37 | -$0.95 |
| EPS | $0.72 | $0.002 | -$0.05 | -$0.12 |
| Diluted EPS | $0.72 | $0.002 | -$0.05 | -$0.12 |
| Weighted Avg Shares Outstanding | $11.64M | $174.33M | $147.46M | $112.59M |
| Weighted Avg Shares Outstanding (Diluted) | $11.64M | $174.37M | $150.70M | $112.59M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan